Michael Anglesio

A local of North Vancouver, Dr. Michael Anglesio studied Microbiology and Immunology McGill University and before joining Dr. Poul Sorensen at UBC to complete a PhD with the pediatric cancer research program. He left Vancouver in 2007 for a post-doctoral fellowship at the Peter MacCallum Cancer Center in Melbourne, Australia with Dr. David Bowtell working with the laboratory that defined “molecular subtypes” of high-grade serous ovarian cancer. In 2010 Dr. Anglesio re-joined the group in Vancouver, this time with the OVCARE team at UBC and the BC Cancer Agency. Dr Anglesio has recently been promoted to an Assistant Professor position at UBC and has been supervising graduate and undergraduate students, and mentoring junior researchers and visiting scientists within OVCARE over the past seven years. His work has centered on further defining subtypes of ovarian cancer. With emerging evidence to suggest ovarian cancers are actually a collection of distinct disease. Dr. Anglesio has led several studies that provide evidence of different origins for each different ovarian cancer type. Most recently he has been focused on uncovering the mechanism through which endometriosis may become malignant and progress into either clear cell or endometrioid ovarian cancer.